サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1393997

構造的心疾患のアジア太平洋市場の2028年までの予測- 地域別分析- 製品別、施術別、エンドユーザー別

Asia Pacific Structural Heart Market Forecast to 2028 - Regional Analysis - by Product, Procedure, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 142 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
構造的心疾患のアジア太平洋市場の2028年までの予測- 地域別分析- 製品別、施術別、エンドユーザー別
出版日: 2023年10月09日
発行: The Insight Partners
ページ情報: 英文 142 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の構造的心疾患市場は、2022年の26億4,967万米ドルから2028年には43億7,455万米ドルに成長すると予測されています。2022年から2028年までのCAGRは8.7%で成長すると推定されます。

構造的心疾患デバイス分野の技術進歩がアジア太平洋の構造的心疾患市場に拍車をかける

経カテーテル手技は、外科的介入に比べて短期間で患者の心臓状態の改善につながります。また、低侵襲手術により手術リスクや心肺リスクが軽減され、患者の満足度が向上しています。TAVRは、変性性大動脈弁狭窄症の治療に合理的な選択肢を提供できることから、より注目を集めています。2017年には、エドワーズライフサイエンス社のEdwards Sapien弁がPARTNER試験で研究中でした。この弁は牛心膜組織弁から作られており、コバルトクロムステント足場に縫合されています。ステントは弁の最大限の折りたたみを可能にし、弁が拡張した後も構造的・半径方向の支持を維持することができます。さらに、最近の心臓構造装置の開発は、心塞栓性脳卒中を予防するための左心房付属器（LAA）および卵円孔開存（PFO）閉鎖術の適応と結果に焦点を当てています。アジア太平洋の構造的心疾患市場のプレーヤーによる技術的進歩の一部を紹介します。2023年2月、メドトロニック社は、先天性または外科的に修復されたRVOTを有する先天性心疾患患者のための開心術に代わる低侵襲のハーモニー経カテーテル肺動脈弁（TPV）システムのリニューアルを発表しました。Evolut FXは既存のEvolutプラットフォームに新機能を追加し、医師の使いやすさと予測可能なバルブの配備を強化しました。2022年5月、フィリップスは構造的心疾患治療用の画像誘導治療ソリューションの新リリースであるエコーナビゲーター4.0を発売しました。EchoNavigator 4.0は、フィリップスのEPIQ CVXiインターベンショナルカーディオロジー超音波システムのユーザーに、同社の画像誘導治療システム"Azurion-platform"でのライブフュージョンイメージングのコントロールを提供します。2021年9月、アボットは、大動脈弁疾患または僧帽弁疾患の患者に対する治療の選択肢を改善するため、Epic PlusおよびEpic Plus Supra Stented Tissue ValvesのFDA承認を取得しました。この新しいデバイスにより、アボット社はEpic外科弁プラットフォームを拡大しました。2021年8月、CORCYMは実世界における僧帽弁、大動脈弁、三尖弁の市販後試験、i.MANTRAに最初の患者を登録しました。最初の移植はイタリアのチッタ・ディ・レッチェ病院で行われ、バイカーボン製大動脈機械弁が使用されました。2021年8月、チェンナイで初のメイド・イン・インド3Dプリント心臓弁が開発されました。新しい心臓弁は3Dプリンターを使って開発され、人工心臓弁に関する問題を克服することができました。したがって、技術の進歩はアジア太平洋の構造的心疾患市場の成長における新たな成長動向につながっています。

アジア太平洋の構造的心疾患市場の概要

アジア太平洋地域の構造的心疾患市場は、中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。この地域は世界の構造的心疾患市場で大きなシェアを占めています。アジア太平洋地域の構造的心疾患市場は、高齢者人口の大幅な増加、心血管疾患の増加、同地域の市場参入企業による革新的な製品の発売などの要因により、予測期間中に大きな成長が見込まれています。

アジア太平洋の構造的心疾患市場の収益と2028年までの予測（金額）

アジア太平洋の構造的心疾患市場のセグメンテーション

アジア太平洋の構造的心疾患市場は、製品、手技、エンドユーザー、国に区分されます。

製品別に見ると、アジア太平洋地域の構造的心疾患市場は、オクルーダー、環状形成リング、心臓弁バルーン、その他に区分されます。2022年のアジア太平洋の構造的心疾患市場では、オクルーダセグメントが最大のシェアを占めています。

手技別に見ると、アジア太平洋の構造的心疾患市場は心臓弁狭窄症、心臓弁逆流症、左心房付属器閉鎖不全症に区分されます。心臓弁狭窄症セグメントは、2022年のアジア太平洋の構造的心疾患市場で最大のシェアを占めました。

エンドユーザー別に見ると、アジア太平洋の構造的心疾患市場は病院、外来手術センター、その他に区分されます。病院セグメントが2022年のアジア太平洋の構造的心疾患市場で最大のシェアを占めました。

国別では、アジア太平洋の構造的心疾患市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋地域に区分されます。2022年のアジア太平洋の構造的心疾患市場は中国が独占。

Abbott Laboratories社、Medtronic Plc社、Boston Scientific Corp社、Artivion Inc社、Edwards Lifesciences Corp社、Lepu Medical Technology Beijing Co Ltd社は、アジア太平洋の構造的心疾患市場で事業を展開している大手企業です。

目次

第1章 イントロダクション

第2章 アジア太平洋の構造的心疾患市場：要点

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の構造的心疾患市場：市場情勢

  • PEST分析
    • アジア太平洋地域のPEST分析
  • 専門家の見解

第5章 アジア太平洋の構造的心疾患市場：主要市場力学

  • 市場促進要因
    • 革新的な構造的心疾患サービスの利用可能性
    • 心血管疾患症例の増加とトレーニングプログラム
  • 主な市場抑制要因
    • 手術費用の高さ
    • 心臓構造装置に関する厳しい規制
  • 主な市場機会
    • 構造的心疾患における人工知能の利用拡大
  • 今後の動向
    • 構造的心疾患デバイス分野における技術の進歩
  • 影響分析

第6章 構造的心疾患市場：アジア太平洋地域の分析

  • アジア太平洋の構造的心疾患市場の収益予測と分析

第7章 アジア太平洋の構造的心疾患市場-2028年までの収益と予測：製品別

  • アジア太平洋の構造的心疾患市場：製品別 - 2021年・2028年収益シェア（%）
  • オクルーダー
  • 環状形成リング
  • 心臓弁バルーン
  • その他

第8章 アジア太平洋の構造的心疾患市場-2028年までの収益と予測：施術別

  • アジア太平洋の構造的心疾患市場：施術別 - 2021年・2028年収益シェア（%）
  • 心臓弁狭窄症
  • 心臓弁逆流
  • 左心房付属器閉鎖

第9章 アジア太平洋の構造的心疾患市場-2028年までの収益と予測：エンドユーザー別

  • アジア太平洋の構造的心疾患市場：エンドユーザー別 - 2021年・2028年収益シェア（%）
  • 病院
  • 外来手術センター
  • 心臓センター

第10章 アジア太平洋地域の構造的心疾患市場-2028年までの収益と予測：国別分析

第11章 アジア太平洋地域の構造的心疾患市場：業界情勢

  • 成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • Artivion Inc
  • Edwards Lifesciences Corp
  • Micro Interventional Devices Inc

第13章 付録

図表

List Of Tables

  • Table 1. China Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. China Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. China Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. China Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. China Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Japan Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Japan Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Japan Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Japan Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Japan Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. India Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. India Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. India Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. India Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. India Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Australia Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Australia Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Australia Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Australia Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Australia Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. South Korea Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. South Korea Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. South Korea Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. South Korea Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. South Korea Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Rest of Asia Pacific Structural Heart Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Rest of Asia Pacific Structural Heart Market, by Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Rest of Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Rest of Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Rest of Asia Pacific Structural Heart Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Recent Organic Growth Strategies in Asia Pacific Structural Heart Market
  • Table 32. Glossary of Terms

List Of Figures

  • Figure 1. Asia Pacific Structural Heart Market Segmentation
  • Figure 2. Asia Pacific Structural Heart Market, by Country
  • Figure 3. Asia Pacific Structural Heart Market Overview
  • Figure 4. Occluders Segment Held Largest Share of Product Segment in Asia Pacific Structural Heart Market
  • Figure 5. Asia Pacific: PEST Analysis
  • Figure 6. Asia Pacific Structural Heart Market Experts' Opinion
  • Figure 7. Asia Pacific Structural Heart Market: Impact Analysis of Drivers and Restraints
  • Figure 8. Asia Pacific Structural Heart Market - Revenue Forecast and Analysis - 2019-2028
  • Figure 9. Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • Figure 10. Occluders: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 11. Annuloplasty Rings: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 12. Heart Valve Balloons: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 13. Others: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 14. Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • Figure 15. Heart Valve Stenosis: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 16. Heart Valve Regurgitation: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 17. Left Atrial Appendage Closure: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 18. Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • Figure 19. Hospitals: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Ambulatory Surgical Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Cardiac Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Asia Pacific Structural Heart Market, by Key Country - Revenue (2021) (US$ Million)
  • Figure 23. Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
  • Figure 24. China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
目次
Product Code: BMIRE00028939

The Asia Pacific structural heart market is expected to grow from US$ 2,649.67 million in 2022 to US$ 4,374.55 million by 2028. It is estimated to grow at a CAGR of 8.7% from 2022 to 2028.

Technological Advancements in the Field of Structural Heart Devices Fuel Asia Pacific Structural Heart Market

Transcatheter procedures lead to improvements in patients' heart conditions in shorter a period compared to surgical intervention. In addition, minimally invasive procedures have reduced surgical and cardiopulmonary risks, which results in increased patient satisfaction. TAVR has gathered more attention due to its ability to offer a reasonable option for the treatment of degenerative aortic stenosis. In 2017, the Edwards Lifesciences's Edwards Sapien valve was under the studies in the PARTNER trial. The valve has been made from a bovine pericardial tissue valve, and it is sutured on a cobalt-chromium stent scaffold. The stent allows the maximum possible folding of the valve, which allows to maintain the structural and radial support once it is expanded. Moreover, the recent developments in structural heart devices focus on indications, and results of left atrial appendage (LAA) and patent foramen ovale (PFO) closure to prevent cardioembolic stroke. A few of the technological advancements by the players in the Asia Pacific Structural Heart Market are mentioned. In February 2023, Medtronic announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patients with native or surgically repaired RVOT. Evolut FX added new features to the existing Evolut platform to enhance ease of use and predictable valve deployment for physicians. In May 2022, Philips launched EchoNavigator 4.0, the new release of its image-guided therapy solution, for the treatment of structural heart disease. EchoNavigator 4.0 provides the users of Philips' EPIQ CVXi interventional cardiology ultrasound system a control of live fusion-imaging on the company's Image Guided Therapy System called "Azurion - platform." In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform. In August 2021, CORCYM enrolled the first patient in the Mitral, Aortic, and Tricuspid Post-Market Study in a Real-World Setting, i.e., MANTRA. The first implantation was performed at Citta di Lecce Hospital in Italy with a Bicarbon aortic mechanical valve. In August 2021, the first Made in India 3D printed heart valve was developed in Chennai. The new heart valves were developed using 3D printers, which could overcome the problems related to artificial heart valves. Therefore, technological advancements are leading to new growth trends in the Asia Pacific Structural Heart Market growth.

Asia Pacific Structural Heart Market Overview

The Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The region holds a significant market share in the global structural heart market. The Asia Pacific structural heart market is expected to witness significant growth during the forecast period due to factors such as the significant growth in elderly population, growing cardiovascular diseases, and launch of innovative products by market players in the region.

Asia Pacific Structural Heart Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Structural Heart Market Segmentation

The Asia Pacific structural heart market is segmented into product, procedure, end user, and country.

Based on product, the Asia Pacific structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on procedure, the Asia Pacific structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on end user, the Asia Pacific structural heart market is segmented into hospitals, ambulatory surgical centres, and others. The hospitals segment held the largest share of the Asia Pacific structural heart market in 2022.

Based on country, the Asia Pacific structural heart market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific structural heart market in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Lepu Medical Technology Beijing Co Ltd are some of the leading companies operating in the Asia Pacific structural heart market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific structural heart market.
  • Highlights key business priorities to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific structural heart market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Asia Pacific Structural Heart Market - by Product
    • 1.3.2 Asia Pacific Structural Heart Market - by Procedure
    • 1.3.3 Asia Pacific Structural Heart Market - by End User
    • 1.3.4 Asia Pacific Structural Heart Market - by Country

2. Asia Pacific Structural Heart Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Structural Heart Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 Asia Pacific PEST Analysis
  • 4.3 Expert's Opinion

5. Asia Pacific Structural Heart Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Availability of Innovative Structural Heart Services
    • 5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Procedures
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Key Market Opportunities
    • 5.3.1 Growing Use of Artificial Intelligence in Structural Heart
  • 5.4 Future Trends
    • 5.4.1 Technological Advancements in the Field of Structural Heart Devices
  • 5.5 Impact analysis

6. Structural Heart Market -Asia Pacific Analysis

  • 6.1 Asia Pacific Structural Heart Market Revenue Forecast and Analysis

7. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by Product

  • 7.1 Overview
  • 7.2 Asia Pacific Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
  • 7.3 Occluders
    • 7.3.1 Overview
    • 7.3.2 Occluders: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Annuloplasty Rings
    • 7.4.1 Overview
    • 7.4.2 Annuloplasty Rings: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Heart Valve Balloons
    • 7.5.1 Overview
    • 7.5.2 Heart Valve Balloons: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by Procedure

  • 8.1 Overview
  • 8.2 Asia Pacific Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
  • 8.3 Heart Valve Stenosis
    • 8.3.1 Overview
    • 8.3.2 Heart Valve Stenosis: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Heart Valve Regurgitation
    • 8.4.1 Overview
    • 8.4.2 Heart Valve Regurgitation: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Left Atrial Appendage Closure
    • 8.5.1 Overview
    • 8.5.2 Left Atrial Appendage Closure: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Asia Pacific Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
  • 9.3 Hospitals
    • 9.3.1 Overview
    • 9.3.2 Hospitals: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Ambulatory Surgical Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgical Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiac Centers
    • 9.5.1 Overview
    • 9.5.2 Cardiac Centers: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 -Country Analysis

  • 10.1 Asia Pacific: Asia Pacific Structural Heart Market
    • 10.1.1 Overview
    • 10.1.2 Asia Pacific: Asia Pacific Structural Heart Market, by Country, 2021 & 2028 (%)
      • 10.1.2.1 China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 China: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.1.3 China: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.1.4 China: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.4.1 China: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.4.2 China: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.1.5 China: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.2 Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Japan: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.2.3 Japan: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.2.4 Japan: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.4.1 Japan: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.4.2 Japan: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.2.5 Japan: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.3 India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 India: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.3.3 India: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.3.4 India: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.4.1 India: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.4.2 India: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.3.5 India: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.4 Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.1 Overview
        • 10.1.2.4.2 Australia: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.4.3 Australia: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.4.4 Australia: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.4.1 Australia: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.4.2 Australia: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.4.5 Australia: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.5 South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.1 Overview
        • 10.1.2.5.2 South Korea: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.5.3 South Korea: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.5.4 South Korea: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.4.1 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.4.2 South Korea: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.5.5 South Korea: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)
      • 10.1.2.6 Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.1 Overview
        • 10.1.2.6.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.2.6.3 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Product, 2019-2028 (US$ Million)
        • 10.1.2.6.4 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.4.1 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.4.2 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (US$ Million)
        • 10.1.2.6.5 Rest of Asia Pacific: Asia Pacific Structural Heart Market, by End User, 2019-2028 (US$ Million)

11. Asia Pacific Structural Heart Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies
    • 11.2.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Artivion Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Micro Interventional Devices Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms